Prostat Cancer Minimal Invasive Surgery Market Prostat Cancer Minimal Invasive Surgery Market : ToC


Prostat Cancer Minimal Invasive Surgery Market

Prostate Cancer Minimally Invasive Surgery Market in North America and Europe (2011 - 2016)

  • Rep Id : TMRGL1
  • Published On : Nov 2011
  • No. of Pages : 83
  • Category : Healthcare

Table of Content

CHAPTER 1 - SUMMARY - Prostate Cancer Market And Minimally Invasive Surgery Market 

1.1 MARKKET SCENARIO

1.2 KEY TRENDS &  INNOVATIONS

1.3 KEY PLAYERS

CHAPTER 2 - INTRODUCTION

2.1 RESEARCH OBJECTIVES

2.2 SCOPE OF THE REPORT

2.3 MARKETS COVERED

2.4 METHODOLOGY

     2.4.1 PRIMARY SURVEY

     2.4.2 SECONDARY RESEARCH

     2.4.3 MARKET SIZING

2.5 FORECAST ASSUMPTIONS\

CHAPTER 3 - MARKET OVERVIEW

3.1 INTRODUCTION

3.2 PROSTATE CANCER: INTRODUCTION

3.3 EPIDEMIOLOGY

3.4 SYMPTOMS

3.5 RISK FACTORS

     3.5.1 AGE

     3.5.2 ETHNICITY

     3.5.3 FAMILY HISTORY/GENETICS

     3.5.4 DIET/LIFESTYLE

     3.5.5 OBESITY

     3.5.6 INFECTION OF THE PROSTATE GLAND

3.6 STAGES

     3.6.1 STAGE I

     3.6.2 STAGE II

     3.6.3 STAGE III

     3.6.4 STAGE IV

3.7 DIAGNOSIS

     3.7.1 DIGITAL RECTAL EXAM (DRE) 

     3.7.2 PROSTATE-SPECIFIC ANTIGEN (PSA) BLOOD TEST

     3.7.3 PROSTATE BIOPSY

     3.7.4 ULTRASOUND

     3.7.5 BONE SCAN

     3.7.6 CT SCAN AND MRI

     3.7.7 PET & SPECT SCANS

     3.7.8 LYMPH NODE BIOPSY

     3.7.9 PROSTASCINT MONOCLONAL ANTIBODY SCAN

CHAPTER 4 - MINIMALLY INVASIVE PROSTATE CANCER SURGICAL TECHNIQUES

4.1 INTRODUCTION

4.2 LAPAROSCOPIC SURGERY

4.3 BRACHYTHERAPY

4.4 CRYOSURGERY

4.5 ROBOTIC SURGERY\

CHAPTER 5 - MARKET DYNAMICS

5.1 DRIVERS

     5.1.1 INCREASE IN ELDERLY MALE POPULATION

     5.1.2 INNOVATIVE TREATMENT OPTIONS

     5.1.3 SIGNIFICANT ADVANTAGE OVER TRADITIONAL METHOD

5.2 RESTRAINTS

     5.2.1 INEFFICIENCY OF SURGERY IN TREATING ADVANCED STAGE CANCER

     5.2.2 LACK OF TECHNOLOGICAL KNOWLEDGE

     5.2.3 HIGH ADVERSE SIDE EFFECTS

List Of Table 

TABLE 1 MINIMALLY INVASIVE PROSTATE CANCER SURGERY DEVICE MARKET (USD MILLION) 

TABLE 2 MINIMALLY INVASIVE PROSTATE CANCER SURGERY MARKET, BY TYPE (USD MILLION) 

TABLE 3 MINIMALLY INVASIVE PROSTATE CANCER LAPAROSCOPIC SURGERY MARKET (USD MILLION) 

TABLE 4 MINIMALLY INVASIVE PROSTATE CANCER BRACHYTHERAPY SURGERY MARKET (USD MILLION) 

TABLE 5 MINIMALLY INVASIVE PROSTATE CANCER CRYOSURGERY MARKET (USD MILLION) 

TABLE 6 MINIMALLY INVASIVE PROSTATE CANCER ROBOTIC SURGERY MARKET (USD MILLION) 

TABLE 7 MINIMALLY INVASIVE PROSTATE CANCER SURGERY HAND INSTRUMENTS MARKET (USD MILLION) 

TABLE 8 MINIMALLY INVASIVE PROSTATE CANCER SURGERY POWERED SURGICAL DEVICES MARKET (USD MILLION) 

TABLE 9 MINIMALLY INVASIVE PROSTATE CANCER SURGERY MONITORING & VISUALIZATION DEVICES MARKET (USD MILLION) 

TABLE 10 MINIMALLY INVASIVE PROSTATE CANCER SURGERY ENDOSURGICAL DEVICES MARKET (USD MILLION) 

TABLE 11 U.S. MINIMALLY INVASIVE PROSTATE CANCER SURGERY (NUMBER OF PROCEDURES) 

TABLE 12 U.S. MINIMALY INVASIVE PROSTATE CANCER SURGERY MARKET, BY DEVICES (USD MILLION) 

TABLE 13 CANADA MINIMALLY INVASIVE PROSTATE CANCER SURGERY (NUMBER OF PROCEDURES) 

TABLE 14 CANADA MINIMALLY INVASIVE PROSTATE CANCER SURGERY MARKET, BY DEVICES (USD MILLION) 

TABLE 15 U.K. MINIMALLY INVASIVE PROSTATE CANCER SURGERY (NUMBER OF PROCEDURES) 

TABLE 16 U.K. MINIMALY INVASIVE PROSTATE CANCER SURGERY MARKET, BY DEVICES (USD MILLION) 

TABLE 17 GERMANY MINIMALLY INVASIVE PROSTATE CANCER SURGERY (NUMBER OF PROCEDURES) 

TABLE 18 GERMANY MINIMALLY INVASIVE PROSTATE CANCER SURGERY MARKET, BY DEVICES (USD MILLION) 

TABLE 19 FRANCE MINIMALLY INVASIVE PROSTATE CANCER SURGERY (NUMBER OF PROCEDURES) 

TABLE 20 FRANCE MINIMALLY INVASIVE PROSTATE CANCER SURGERY MARKET, BY DEVICES (USD MILLION) 

TABLE 21 ITALY MINIMALLY INVASIVE PROSTATE CANCER SURGERY  (NUMBER OF PROCEDURES) 

TABLE 22 ITALY MINIMALLY INVASIVE PROSTATE CANCER SURGERY MARKET, BY DEVICES (USD MILLION) 

TABLE 23 SPAIN MINIMALLY INVASIVE PROSTATE CANCER SURGERY (NUMBER OF PROCEDURES) 

TABLE 24 SPAIN MINIMALLY INVASIVE PROSTATE CANCER SURGERY MARKET, BY DEVICES (USD MILLION) 

TABLE 25 ANGIODYNAMICS, INC. TOTAL REVENUES AND R&D EXPENSES (USD THOUSAND) 

TABLE 26 ANGIODYNAMICS, INC. BUSINESS SEGMENT REVENUE (USD THOUSAND) 

TABLE 27 BSD MEDICAL CORPORATION – TOTAL SALES & R&D EXPENDITURE (USD MILLION) 

TABLE 28 COVIDIEN AG  - TOTAL REVENUES & R&D EXPENDITURE (USD MILLION) 

TABLE 29 COVIDIEN AG - REVENUES BY SEGMENT (USD MILLION) 

TABLE 30 OLYMPUS CORPORATION - TOTAL REVENUES & R&D  EXPENDITURE (USD MILLION) 

TABLE 31 OLYMPUS CORPORATION - REVENUES BY SEGMENTS (USD MILLION) 

TABLE 32 SIEMENS HEALTHCARE – HEALTHCARE SEGMENT SALES & R&D EXPENSES (USD MILLION) 

TABLE 33 INTUITIVE SURGICAL, INC. – REVENUES & R&D EXPENSES (USD MILLION) 

 

List Of Figure

FIG. 1 MINIMALLY INVASIVE PROSTATE CANCER SURGICAL DEVICE MARKET

(BY GEOGRAPHY) 

FIG. 2 PROSTATE CANCER MINIMALLY INVASIVE SURGICAL

FIG. 3 PROSTATE CANCER MINIMALLY INVASIVE SURGERY MARKET 

(BY APPLICATION) 

FIG. 4 PROSTATE CANCER MINIMALLY INVASIVE LAPAROSCOPIC SURGERY DEVICE MARKET (BY TYPES) 

FIG. 5 PROSTATE CANCER MINIMALLY INVASIVE BRACHYTHERAPY DEVICE MARKET (BY TYPES) 

FIG. 6 PROSTATE CANCER MINIMALLY INVASIVE CRYOSURGERY DEVICE MARKET (BY TYPES) 

FIG. 7 PROSTATE CANCER MINIMALLY INVASIVE ROBOTIC SUSRGERY DEVICE MARKET (BY TYPES) 

FIG. 8 GROWING MALE POPULATION (2010 – 2050): AGED POPULATION

(>40 YEARS) IS SIGNIFICANTLY INCREASING

FIG. 9 MINIMALLY INVASIVE PROSTATE CANCER SURGICAL DEVICES MARKET SEGMENTATION

FIG. 10 PROSTATE CANCER MINIMALLY INVASIVE HAND DEVICE MARKET

FIG. 11 PROSTATE CANCER MINIMALLY INVASIVE POWERED SURGICAL DEVICE MARKET

FIG. 12 PROSTATE CANCER MINIMALLY INVASIVE MONIORING & VISUALIZATION DEVICE MARKET

FIG. 13 PROSTATE CANCER MINIMALLY INVASIVE ENDOOSURGICAL DEVICE MARKET

FIG. 14 MARKET SHARE OF MAJOR COMPETITORS IN MINIMALLY INVASIVE PROSTATE CANCER SURGICAL DEVICE MARKET (2011) 

Minimally Invasive Surgery Market And Prostate Cancer Marke